Showing 301 - 320 results of 96,802 for search '(( 10 ((nn decrease) OR (we decrease)) ) OR ( 50 ((ns decrease) OR (mean decrease)) ))', query time: 0.77s Refine Results
  1. 301
  2. 302
  3. 303
  4. 304
  5. 305
  6. 306
  7. 307
  8. 308
  9. 309
  10. 310
  11. 311
  12. 312
  13. 313
  14. 314

    C2GnT1 gene knockdown decreases C2-O-sLe<sup>X</sup> glycoproteins and C2GnT1 activity. by Catherine A. St. Hill (357388)

    Published 2013
    “…Note the absence of a detected C2GnT1 protein 50 kDa band. (D) We observed a 30–40% decrease in reactivity with CHO-131 mAb by flow cytometry for LS174T and HepG2 cells that contained C2GnT1 shRNA. …”
  15. 315

    Microfluidic Device for Automated Synchronization of Bacterial Cells by Seth M. Madren (2033833)

    Published 2012
    “…We report the development of an automated microfluidic “baby machine” to synchronize the bacterium <i>Caulobacter crescentus</i> on-chip and to move the synchronized populations downstream for analysis. …”
  16. 316

    Microfluidic Device for Automated Synchronization of Bacterial Cells by Seth M. Madren (2033833)

    Published 2012
    “…We report the development of an automated microfluidic “baby machine” to synchronize the bacterium <i>Caulobacter crescentus</i> on-chip and to move the synchronized populations downstream for analysis. …”
  17. 317
  18. 318

    Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy by Yong-Chul Kim (1637572)

    Published 2013
    “…</p><p>Results</p><p>The mean value of pcUACR at 12-week and 16-week visits (primary outcome) was decreased more in the Tac group compared to the control group (–52.0±26.4 vs –17.3±29.3%, p = 0.001). …”
  19. 319
  20. 320

    Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant by Ittipat Meewan (7455041)

    Published 2019
    “…Hepatitis C virus (HCV) is a human pathogen with high morbidity. The HCV NS3/4A protease is essential for viral replication and is one of the top three drug targets. …”